Moreover, they reported a decrease in sexual satisfaction and in sexual activity.
Is Viagra an Option for Female Sexual Dysfunction?
A double-blind, crossover, placebo-controlled study design was performed. The efficacy of treatment was the primary end point based on the proportion of successful attempts, defined as sexual arousal levels, occurring after dosing. Safety was considered a further end point of this study, data being collected throughout the study period, and included recording adverse events, vital signs, and changes in laboratory test values for standard hematology and biochemistry variables. Patients provided information recorded on diary cards and were reviewed at each study visit concerning sexual activity. After defining inclusion criteria at the screening, according to a computer-generated list of random number groups, each woman was randomly allocated to one of the two possible sequences, each of which constituted two medication series: sildenafil 100 mg/placebo (A sequence) and placebo/sildenafil 100 mg (B sequence).
How much time does it take for Viagra to work for females?
Women were assessed before being treated and during each treatment by one investigator. Both the woman and the attending doctor carrying out the procedure were blinded to the two drugs. The investigator was not involved in the recruitment of the women and did not know the computer-generated randomization list and the assignment of the treatment group according to the sequence of recruitment. The codes were broken after the study was completed. The crossover study design was used to define whether the treatment with sildenafil was effective with respect to placebo. The mean (±SD) usage of sildenafil and placebo
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Kamagra Oral Jelly | 100mg | 110 + 9 Sachets | 334.87€ 318.92€ | |
| Viagra Generic | 50mg | 120 + 6 Pills | 129.64€ 123.47€ | |
| Viagra Generic | 25mg | 10 Pills | 25.19€ 23.99€ | |
| Viagra Generic | 100mg | 20 Pills | 45.58€ 43.41€ | |
| Viagra Generic | 25mg | 120 + 6 Pills | 125.56€ 119.58€ | |
| Viagra Generic | 150mg | 120 + 8 Pills | 177.58€ 169.12€ | |
| Viagra Generic | 100mg | 10 Pills | 28.91€ 27.53€ | |
| Viagra Generic | 25mg | 90 + 6 Pills | 105.03€ 100.03€ | |
| Kamagra | 100mg | 20 Pills | 86.09€ 81.99€ | |
| Kamagra Oral Jelly | 100mg | 220 + 18 Sachets | 662.24€ 630.70€ | |
| Viagra Generic | 150mg | 10 Pills | 36.73€ 34.98€ | |
| Viagra Generic | 25mg | 360 + 10 Pills | 213.68€ 203.50€ | |
| Viagra Generic | 100mg | 270 + 10 Pills | 270.47€ 257.59€ | |
| Kamagra Soft Tabs | 100mg | 272 + 12 Pills | 593.42€ 565.16€ |
was, respectively, 2.1 (±0.4) and 2.9 (±0.4) times weekly. It is interesting to note that all women
What other information should I know?
Hormones were sampled during the morning on cycle days 12–17. Plasma T and PRL were measured using commercially available ELISA kits (Elecsys Systems 2010). Plasma levels of FT were also measured using ELISA kits (DSX System; DRG Instruments GmbH, Marburg/Lahn, Germany). Each woman underwent a Sexual History Interview (SHI) (24) that was conducted in a private room alone with the female sexual disorder therapist: 60–90 minutes were needed for the interview, and 15–30 minutes to write the justification. Information was sought about any changes in number of sexual fantasies and arousal and about other sexual experiences such as orgasmic and coital frequency and enjoyment of sexual activities.
Increased genital blood flow
Women with dysphoric arousal, a sensation of unpleasant genital engorgement (25), were excluded from the study. The American Foundation for Urologic Disease definition of Female Sexual Function Disorders (26) was used to define SAD, that is, the persistent or recurring inability to attain or maintain sufficient sexual excitement, causing personal distress, which may be expressed as a lack of subjective excitement or genital (lubrication/swelling) or other somatic responses. The women with acquired sexual dysfunction and SAD were the focus of our study. Finally, one of our hypotheses was that if arousal were enhanced, orgasm could possibly be facilitated. To measure sexuality we used the Personal Experiences Questionnaire (PEQ) (27), a self-reporting questionnaire based on the McCoy Female Sexuality Questionnaire (28). recorded using each drug for all sexual activities.
- Sildenafil is often known by the brand name Viagra, primarily for men.
- Researchers are exploring other PDE5 inhibitors for women’s sexual health.
- Efficacy of sildenafil in women might depend on underlying health conditions.
- Women with cardiovascular issues should be particularly cautious with sildenafil.
- Some women report increased sexual satisfaction after using sildenafil.
- Medical advice is crucial before women consider sildenafil as a treatment.
Changes in sexuality produced by drug administrations
Chemical synthesis
The last observation carried forward was used to select data such that missing data were replaced by values from the last available assessment during treatment before the respective assessment. Furthermore, women who stopped treatment for adverse events were included in the analysis. For comparisons among baseline, sildenafil 100 mg, and placebo sexual PEQ scores, the nonparametric Wilcoxon’s rank-sum test was used. Separate analyses were performed for the arousal score (primary end point) and desire, orgasm, enjoyment of sexual activities, satisfaction with frequency, and frequency of intercourse. Paired Student’s t-test was performed to compare changes between baseline sildenafil and placebo values of clitoral arterial blood flow.
Inclusion Criteria
Considering the order in which the treatments were allocated, data was analyzed by Student’s t-test, using the Bonferroni method of correction for multiple comparisons if a significant F ratio was found. Statistical analysis was carried out using the Primer of Biostatistics statistical computer package (29). Of the 36 women enrolled in the study, 32 women aged 27–41 with a mean age (±SD) of 33 (±3.1) and a BMI 25.0 ± 3.5 provided information at each treatment to be included in the analyses. Four women were excluded after assessment at baseline: [1] two for anovulatory cycles and [2] two for refused treatment. The mean duration of diabetes was 12.1 ± 8.5 years, and the mean HbA1c value was 8.0% ± 1.8%. were noticed though the analysis of PEQ items.
| Parameter | Description | Typical Values | Notes |
|---|---|---|---|
| Absorption Rate | Time to reach peak plasma levels | 30-120 minutes | Varies with food intake |
| Half-Life | Duration of drug activity | 4 hours | Metabolized mainly in liver |
| Bioavailability | Percentage of drug absorbed | 40-50% | Affected by gastric pH |
| Metabolism | Enzymes involved | CYP3A4 | Liver metabolism mainly |
| Excretion | How drug is eliminated | Feces and urine | Mainly fecal excretion |
Table 1 shows the changes from baseline of qualitative and quantitative sexual
- Sildenafil may help women with conditions like arousal disorder, but evidence varies.
- There is ongoing research into safe, effective female-specific doses of sildenafil.
- Side effects experienced by women can include dizziness, nausea, or visual disturbances.
- Consumption of alcohol while on sildenafil can increase side effect risks.
- Female sexual dysfunction can have psychological, hormonal, and physical causes.
- Sildenafil is not a cure-all; proper diagnosis is important for targeted treatment.
behaviors according to the treatment and the efficacy of sildenafil and placebo.
What special precautions should I follow?
Each woman took sildenafil or placebo 1 hour before each sexual intercourse. The usage of the drug was not more than once daily. Each woman received each treatment buy sildenafil citrate online canada for 8-week periods. There was a 7-day washout period between treatments. We chose a 1-week washout period on the basis of our previous studies using a similar intervention by which we did not observe any carryover effect (22, 34).
Key takeaways
The PEQ was used at baseline, at the washout, and after treatments. Arterial clitoral color Doppler ultrasound was performed at baseline and during the usage of drugs. All adverse events reported by the woman were recorded, irrespective of any random relationship with the study drug. Intention-to-treat analyses were performed for all efficacy variables and included all patients who had a baseline evaluation and had at least one efficacy assessment after the baseline visit. We included in the analysis the subjects that had missing information on one or more questionnaire items. Data indicate that sildenafil improved [1] the experience
The Sexy Science Behind Dare to Play
Women were excluded from the study if they had a history of hypertension, coronary artery disease, or thromboembolic disorder; impaired hepatic and renal function and neoplasia; were taking hormone therapy or oral contraceptives; had a history of smoking and alcohol abuse; did not have a sexual partner; were affected by situational sexual dysfunction with their partner; or had a partner with sexual dysfunction. All patients admitted to the screening phase had regular menstrual cycles (mean cycle length 26.7 ± 4.2 days), with ovulation. To confirm the ovulatory cycle, ultrasound was performed on days 10, 12, and 15 of the cycle and serum P concentrations were measured at days 21 and 25 of the cycle. Menstrual cycle was defined as ovulatory when the serum P was >18 IU/mL. The P level was measured using commercially available enzyme-linked immunoassorbent assay (ELISA) kits (Elecsys System 2010; Roche, Monza, Italy).
Exclusion Criteria
Moreover, during the screening period subjects underwent a physical examination, including assessment of vital signs and an ECG. A venous blood sample was collected on the day of enrollment to determine hemoglobin glycosylated (HbA1c). HbA1c was determined using the Cobas Integra assay (Roche, Basel, Switzerland), where the normal rage is 4.0%–6.0%. Subjects with HbA1c ≥10% were excluded from the study because they were considered to be affected by diabetes that was not well-controlled. Blood samples were obtained from all study participants to measure hormonal levels of T, FT, and PRL. of arousal (P<.001), orgasm (P<.001), and enjoyment (P<.001) with
- Sildenafil is a medication primarily used to treat erectile dysfunction in men.
- Women sildenafil is an off-label use aimed at improving female sexual arousal.
- Clinical trials are ongoing to assess efficacy of sildenafil for women.
- Side effects of sildenafil may include headaches, flushing, and nasal congestion.
- Women may experience increased blood flow and libido with sildenafil.
- Proper dosage and medical consultation are essential before use.
respect to baseline; and [2] the experience of
What should I know about storage and disposal of this medication?
Using the PEQ, it was possible to assess the efficacy of each treatment with respect to baseline values. Qualitative items were answered on a 5-point Likert scale, ranging from 1, not at all, to 5, a great deal. Quantitative items were answered as 0, never; 1, less than once a week; 2, once or twice a week; 3, several times a week; 4, once a day/sometimes twice; and 5, several times a day. The PEQ was completed by each woman and handed back to the fieldworker. Finally, each woman underwent color Doppler ultrasound to measure clitoral blood flow.
Cite this article
Ultrasound was performed using a SonoAce 8800 (Medison Co., Seoul, Korea) with a 7.5-MHz linear transducer by the same investigator. Each woman was scanned in the gynecological position. The Doppler translabial probe was placed sagittally on the clitoris at an angle of <20 degrees, without exerting any significant pressure on the tissues. After identifying the clitoral artery using color flow mapping, the Doppler probe was positioned over the vessel and at least three sequential Doppler waveforms were obtained. The peak systolic velocity (PSV), the end diastolic velocity (EDV), the resistance index (RI = PSV − EDV/PSV), and the pulsatility index (PI = PSV − EDV/mean flow velocity of clitoral artery) were calculated. arousal (P<.01) and orgasm (P<.05) with respect to placebo.
Get on the List
Plasma concentrations of T (0.4 ± 0.6 ng/mL; normal range, 0.3–1.2 ng/mL), FT (1.3 ± 0.7 pg/mL; normal range, 0.3–3.2 pg/mL)19, and PRL (10.5 ± 3.5 ng/mL; normal range, 5–25 ng/mL) were normal. Moreover, 4 (12.5%) of 32 women in the B sequence did not complete the study for adverse events, all during sildenafil usage. They stopped taking the drug for [1] headache, vision problems, and nausea (n = 1), [2] vision problem and headache (n = 1), and [3] headache and nausea (n = 2). Therefore, the incidences of the most commonly recorded adverse events reported by subjects during the use of sildenafil were headache (12.5%), nausea (6.2%), and vision problem (6.2%). Each adverse event was predominantly transient and mild in nature.
Complementary and Alternative Options for Low Libido
During the study, each women had well-controlled diabetes. The mean HbA1c value obtained during each treatment was similar to that observed at baseline (P=NS). The BMI did not show any significant variation with respect to baseline values (P=NS). The sexual interview showed that the mean duration of sexual dysfunction was 3.5 years (range, 2.2–4.5 years). Subjects mainly reported arousal and orgasm difficulties and dyspareunia.